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Abstract The eye lens small heat shock proteins (sHSP), KA-
and KB-crystallins, have been shown to function like molecular
chaperones, both in vitro and in vivo. It is essential to assess the
protective e¡ect of KA- and KB-crystallins under native condi-
tions to extrapolate the results to in vivo conditions. Insulin and
K-lactalbumin have widely been used to investigate the chaper-
one mechanism of K-crystallin under native conditions. Due to
its smaller size, insulin B-chain may not represent the binding
of putative physiological substrate proteins. As it stands, the
aggregation of K-lactalbumin and binding of K-crystallin to it
varies under di¡erent experimental conditions. Abrin, a ribo-
some inactivating protein isolated from the seeds of Abrus pre-
catorius, consists of a 30 kDa A-chain and a lectin-like B-chain
of 33 kDa joined by a single disul¢de bond. Reduction of the
disul¢de link between the two chains of abrin leads to the ag-
gregation of the B-chain. In this study, we demonstrate that
dithiothreitol (DTT)-induced aggregation of abrin B-chain could
be monitored by light scattering similar to that of insulin. Mo-
reso, this process could be suppressed by recombinant human
KA- and KB-crystallins in a concentration dependent manner,
notably by binding to aggregation prone abrin B-chain. SDS^
PAGE and HPLC gel ¢ltration analysis indicate that there is
a soluble complex formation between K-crystallin and abrin
B-chain. Interestingly, in contrast to insulin, there is no signi¢-
cant di¡erence between KA- and KB-crystallin in suppressing
the aggregation of abrin B-chain at two di¡erent temperatures
(25 and 37‡C). HSP26, an another small heat shock/K-crystallin
family protein, was also able to prevent the DTT-induced ag-
gregation of abrin. These results suggest that due to relatively
larger size of its B-chain (33 kDa), compared to insulin B-chain
(about 3 kDa), abrin may serve as a better model substrate for
in vitro chaperone studies of K-crystallin and as well as other
sHSP. 8 2002 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
K-Crystallin, the major eye lens protein, belongs to small
heat shock protein (sHSP) family, due to its structural and
functional similarities [1^3]. The lenticular K-crystallin con-
sists of KA and KB subunits of 20 kDa each and exists as a
polydisperse oligomer with an average molecular mass of 600^
800 kDa [2]. More recently K-crystallin has been shown to be
present in a number of non-lenticular tissues [2^5], suggesting
that it may have a more general cellular function. Like all
other sHSP, K-crystallin acts as a molecular chaperone by
preventing the aggregation of other proteins denatured by
heat or other stress conditions [2,6^10]. Although, the mech-
anism of chaperone function of K-crystallin is not fully under-
stood, it was shown that K-crystallin speci¢cally recognizes
aggregation-prone, non-native structures that occur early on
the denaturation pathway of protein [11^13]. Numerous stud-
ies have shown that the chaperone activity of the proteins is
dependent on the presence of surface-exposed hydrophobic
patches [7,14^16]. K-Crystallin forms stable complexes with
a wide variety of chemically or thermally denatured proteins
[9,11,13,17,18]. Both KA and KB subunits participate in chap-
erone activity [10,13,16,19,20]. Many of the above mentioned
in vitro studies and some studies with lens epithelial cell lines
[21,22] and K-crystallin knockout mice [23,24] suggest that the
chaperone function of K-crystallin is of considerable impor-
tance in vivo and in particular in the prevention of cataract
formation.
In view of the suggested physiological roles of K-crystallin,
a variety of substrates and strategies have been used in study-
ing the mechanism of chaperone function of K-crystallin. Ex-
cept insulin assay, in many aggregation assays, K-crystallin is
shown to undergo some structural perturbation due to heat,
chemical (like guanidine hydrochloride) or physical (UV light)
factors [15,19,25,26]. Therefore insulin has been widely used
to study the chaperone function of K-crystallin under native
conditions. Though, not as widely as insulin, K-lactalbumin is
also used to study the chaperone activity of K-crystallin under
native conditions. However, K-lactalbumin requires speci¢c
experimental conditions for aggregation and the extent of ag-
gregation as well as the unfolding intermediates vary accord-
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ing to the experimental conditions [17,18,25,27]. K-Crystallins
have also been shown to prevent the aggregation/inactivation
of many enzymes caused by heat, UV radiation, sugars and
other chemicals [19,28,29,30]. Though heat-induced aggrega-
tion of citrate synthase [19,29] and alcohol dehydrogenase
[10,19] have been commonly used to assay chaperone activity,
the lowest temperature required to induce considerable aggre-
gation is 40^45‡C. Although, insulin aggregation has advan-
tages, extrapolating the mechanism(s) based on binding of
insulin B-chain to K-crystallin may not be appropriate due
to its small size (3 kDa). Moreso, many, if not all, putative
physiological substrate proteins of K-crystallin may be rela-
tively larger in size at least to the order of about 7^10 times
the insulin B-chain. In this context, we investigated whether
dithiothreitol (DTT)-induced aggregation of abrin can be used
to understand the chaperone function of K-crystallin under
native conditions.
Abrin is a type II ribosome inactivating protein isolated
from the seeds of Abrus precatorius. It consists of two sub-
units, a 30 kDa A-chain and a lectin-like B-chain of 33 kDa
joined by a single disul¢de bond [31]. The A-chain is the toxic
one having the RNA N-glycosidase activity and brings about
inhibition of protein synthesis [32]. The B-chain is essential for
the entry of the toxin into the cell as it binds to the cell sur-
face glycoproteins or receptors [31,32]. In vitro, reduction of
a disul¢de link between the two chains of abrin by DTT or
2-mercaptoethanol leads to aggregation of the B-chain. This
property of abrin B-chain could be utilized for studying the
activities of many chaperones including K-crystallin by quan-
tifying their capacity in preventing this aggregation. However,
so far, abrin aggregation has not been employed to study the
chaperone activity of any molecular chaperone.
In the present communication, we demonstrate that abrin
B-chain aggregates when reduced with DTT with similar
kinetics to that of insulin B-chain aggregation and KA- and
KB-crystallins prevent this aggregation in a concentration-
dependent manner, suggesting that abrin could be used as
an in vitro substrate to understand chaperone mechanism of
K-crystallin.
2. Materials and methods
2.1. Puri¢cation of abrin
The protein was puri¢ed from the seeds of A. precatorius as de-
scribed previously [33]. Brie£y, the seed kernels were soaked overnight
in 5% acetic acid and homogenized. The crude extract was subjected
to 30 and 90% ammonium sulfate precipitation followed by extensive
dialysis in 10 mM phosphate-bu¡ered saline (PBS), pH 7.4. The dia-
lyzed protein was centrifuged and the supernatant was loaded onto
the Lactamyl^Sepharose a⁄nity column equilibrated with PBS. The
unbound proteins were removed by washing the column with PBS.
The bound proteins were then eluted with 0.4 M lactose. The lactose
fractions were pooled and loaded onto the gel ¢ltration column. The
proteins were eluted with 20 mM PBS. The fractions corresponding to
peak II were pooled, dialyzed extensively and lyophilized. Protein
concentration was determined using its molar extinction coe⁄cient
100 170 M31 cm31.
2.2. Overexpression and puri¢cation of human recombinant KA- and
KB-crystallins
Bacterial (BL21) cells containing expression vectors of human KA-
and KB-crystallin were kindly provided by Dr. J. Mark Petrash
(Washington University, St. Louis, MO, USA). Proteins from 1 l
cultures were extracted and puri¢ed to apparent homogenity accord-
ing to the procedures described previously [19]. The puri¢ed recombi-
nant K-crystallins showed on SDS^polyacrylamide gel a single band
corresponding to protein with a molecular weight of approximately
20 kDa. Protein concentration was determined spectrophotometrically
using the molar extinction coe⁄cient, O280, of 16 500 and 19 000 M31
cm31 for KA- and KB-crystallin, respectively [10].
2.3. Chaperone activity
Chaperone activity of puri¢ed recombinant human KA- and KB-
crystallins and HSP26 (a gift from Prof. J. Buchner, Technical Uni-
versity Munich) was assessed by measuring their ability to prevent
DTT-induced aggregation of insulin B-chain [8,14].
2.4. Abrin aggregation
The aggregation of abrin (675 Wg/ml) in 50 mM sodium phosphate
bu¡er, pH 7.4 containing 100 mM NaCl, was initiated by the addition
of 30 mM DTT in 1 ml reaction volume at required temperatures
(mentioned in the legends to ¢gures). The extent of B-chain aggrega-
tion was measured as a function of time by monitoring light scattering
at 400 nm in a Cary Bio 100 spectrophotometer.
2.5. Suppression of abrin aggregation by KA- and KB-crystallins and
HSP26
The suppression of aggregation of abrin B-chain by KA- and
KB-crystallins and HSP26 was studied by incubating abrin with the
required concentrations of either KA- or KB-crystallin or HSP26 for
10 min. Aggregation was initiated by the addition of 30 mM DTT and
the extent of aggregation was measured as mentioned above. The
relative chaperone activity of KA- and KB-crystallin and HSP26 was
calculated considering abrin aggregation in the absence of crystallins
and HSP26 as 100% after 70 min of incubation with DTT.
2.6. SDS^PAGE
Abrin aggregation in the presence or absence of either KA- or KB-
crystallin was analyzed on 12% polyacrylamide gels in the presence of
SDS. The aggregation of abrin in the presence or absence of KA- and
KB-crystallin was initiated as described above. After 70 min, samples
were centrifuged at 10 000Ug for 15 min and supernatant was col-
lected. The precipitate was washed twice with phosphate bu¡er and
resuspended in the same bu¡er. Required amount of supernatant and
redissolved precipitate samples were treated with equal volumes of 2U
SDS sample bu¡er and electrophoresis was carried out in a Bio-Rad
mini gel apparatus.
2.7. Gel ¢ltration
The formation of complex between K-crystallins or HSP26 and the
B-chain of abrin was studied by gel ¢ltration chromatography on a
600U7.5 mm TSK-G2000 SW column (Tosoh Co., Japan) using a
Shimadzu HPLC system. The column was equilibrated with 0.1 M
sodium phosphate bu¡er, pH 6.7, containing 0.1 M sodium sulfate at
Fig. 1. The chaperone activity of KA- and KB-crystallins and
HSP26 at 25‡C. Insulin (0.4 mg/ml in 50 mM phosphate bu¡er, pH
7.4) was reduced with 20 mM DTT and the aggregation of the insu-
lin B-chain in the absence (trace 1) and presence of 0.3 mg/ml KA-
(trace 2), HSP26 (trace 3) and KB-crystallin (trace 4) was monitored
by measuring the apparent absorption at 400 nm.
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Fig. 2. DTT-induced aggregation of abrin B-chain and suppression
by KB-crystallin at 25‡C. Abrin (0.675 mg/ml in 50 mM phosphate
bu¡er, pH 7.4, containing 100 mM NaCl) was reduced with 30 mM
DTT in a ¢nal volume of 1 ml and the aggregation of the B-chain
in the absence (1) and presence of 0.10 (2), 0.20 (3), 0.30 (4), 0.40
(5), 0.5 (6) and 0.60 mg/ml of KB-crystallin (7) was monitored by
measuring the apparent absorption at 400 nm. The graph is a repre-
sentative plot of the three individual experiments.
Fig. 3. Suppression of abrin B-chain aggregation by KA- and KB-
crystallins and HSP26 at 25‡C. Abrin (0.675 mg/ml in 50 mM phos-
phate bu¡er, pH 7.4, containing 100 mM NaCl) was reduced with
30 mM DTT and the aggregation of the abrin B-chain in the ab-
sence (1) and presence of 0.5 mg/ml KA- (3), HSP26 (4) and KB-
crystallin (5) was monitored by measuring the apparent absorption
at 400 nm. As a negative control we have also assessed the aggrega-
tion of abrin B-chain in the presence of 0.5 mg/ml BSA (2).
Fig. 4. SDS^PAGE proof of formation of complex between abrin B-chain and KA- or KB-crystallin. Abrin (0.675 mg/ml in 50 mM phosphate
bu¡er, pH 7.4, containing 100 mM NaCl) was reduced with 30 mM DTT in a ¢nal volume of 1 ml and the aggregation of the B-chain in the
absence (1) or presence of 0.10 (2), 0.20 (3), 0.30 (4), 0.40 (5), 0.5 (6) and 0.60 (7) mg/ml of KB-crystallin (A) and KA-crystallin (B). At the end
of 70 min, incubation samples were centrifuged at 10 000Ug and supernatant was collected. Pellet was washed twice with the incubation bu¡er
and reconstituted in 200 Wl of the same bu¡er. Supernatant and reconstituted precipitate samples were treated with equal volumes of 2U SDS
sample bu¡er and loaded onto a 12% polyacrylamide gel. MW, molecular weight standards (34, 29, 24 and 18 kDa in descending order).
FEBS 26203 19-6-02
G.B. Reddy et al./FEBS Letters 522 (2002) 59^64 61
a £ow rate of 1 ml/min. Abrin (0.675 mg/ml) in the absence or pres-
ence 0.5 mg/ml of KA- and KB-crystallin and HSP26 was reduced with
30 mM DTT as described above. After 70 min the samples were
centrifuged at 10 000Ug for 15 min and the supernatants (20 Wl)
were loaded on to the column.
3. Results and discussion
The ability of recombinant human KA- and KB-crystallins
and HSP26 in suppressing the aggregation of insulin B-chain
is shown in Fig. 1. While both KA- and KB-crystallins are
e¡ective in preventing the aggregation of insulin B-chain,
KB is approximately three times more e¡ective than KA at
25‡C for the same amount of the protein. HSP26 is slightly
better than KA-crystallin in suppressing the aggregation of
insulin (Fig. 1).
Reduction of the disul¢de bond bridging the abrin A- and
B-chain leads to the unfolding and aggregation of the B-chain.
The aggregation reaction can be monitored by simple light
scattering similar to that of insulin. Fig. 2 shows the abrin
B-chain aggregation kinetics due to light scattering at 400 nm.
Aggregation starts after 25 min of DTT addition and keeps
increasing before it reaches a saturation level by 60^70 min.
Interestingly this aggregation can be suppressed by KB-crys-
tallin in a concentration-dependent manner (Fig. 2). Similarly,
KA-crystallin and HSP26 are also e¡ective in suppressing
DTT-induced aggregation of abrin B-chain (Fig. 3). However,
an unrelated protein, bovine serum albumin (BSA), did not
prevent the aggregation of abrin (Fig. 3). About 90% protec-
tion against abrin aggregation is seen at an approximate stoi-
chiometry 1:1.2^1.5 of abrin B-chain and KA-, KB-crystallin
and HSP26 monomers.
Fig. 5. HPLC analysis of the complex formation between KB-crystallin and abrin B-chain or between HSP26 and abrin B-chain by gel ¢ltration
chromatography on TSK-G-2000SW column. Elution pro¢le of KB-crystallin (A), HSP26 (B), abrin (C), DTT (D), abrin reduced with DTT
(E) and abrin reduced with DTT in the presence of either KB-crystallin (F) or HSP26 (G). Details were given in Section 2. H: Pro¢le of molec-
ular weight markers with retention time in parentheses: thyroglobulin (11), BSA (14.3), ovalbumin (15.7) and carbonic anhydrase (17.5).
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In the case of insulin, K-crystallin binds to the non-native
conformer of insulin B-chain and prevents further aggregation
[8,14]. To understand whether K-crystallin also binds to the
B-chain of abrin and forms a soluble and stable complex,
soluble and precipitate fractions of aggregation reaction mix-
tures of abrin with and without KA- and KB-crystallin were
analyzed by SDS^PAGE. In the absence of K-crystallin, abrin
B-chain is precipitated completely leaving A-chain in solution
(Fig. 4). But when K-crystallin was present during aggregation
it prevented the precipitation of B-chain from solution in a
concentration-dependent manner (Fig. 4), which paralleled the
decrease in light scattering (Fig. 2). These results suggest that
probably K-crystallin is binding to aggregation-prone abrin
B-chain mostly in a non-native conformer and forming stable
soluble complexes thereby preventing the precipitation of
B-chain.
Further, the complex formation between K-crystallins or
HSP26 and abrin B-chain was shown by gel ¢ltration.
KB-Crystallin and HSP26 eluted in the void volume (11.1
min), abrin eluted as a 65 kDa protein (14.4 min) and DTT
in exclusion volume (24. 9 min) as expected (Fig. 5). Upon
reduction with DTT and after centrifugation, the native abrin
peak had disappeared and the unfolded abrin A-chain (in the
supernatant) eluted together with DTT in exclusion volume as
abrin B-chain was precipitated out. While the area under peak
for only DTT was 35 867, it was 54 788 for DTT and abrin
A-chain peak together, indicating DTT and abrin A-chain
coelution. This is not surprising as the subunits of many
unfolded proteins have been shown to exist in expanded state
or in the compact form and thereby eluting in either void
volume [34] or in exclusion limits (P. Raghu, G.B. Reddy,
B. Sivakumar unpublished data; [35]), respectively than the
usually expected molecular weight volumes on gel ¢ltration.
Interestingly, the area under peak for KB-crystallin (41 861)
and HSP26 (15 261) was higher when incubated with abrin
and DTT for 70 min compared to the native KB-crystallin
(16 524) and HSP26 (5929) alone, suggesting the formation
of KB-crystallin^abrin B-chain or HSP26^abrin B-chain com-
plex (Fig. 5). Interpretation of HPLC data based on area
under the peak may not be direct proof to demonstrate the
complex formation between chaperone and abrin B-chain.
Therefore, the peaks corresponding to KB-crystallin^abrin
B-chain (peak 1 of Fig. 5F) or HSP26^abrin B-chain (peak
1 of Fig. 5G) complex were further analyzed by SDS^PAGE
which showed bands corresponding to KB-crystallin and abrin
B-chain or HSP26 and abrin B-chain, respectively (data not
shown).
Previously it was reported that, despite high sequence ho-
mology, KA- and KB-crystallins behave di¡erently with in-
creasing temperature (even within the physiological range)
with respect to their chaperone potential, secondary and
tertiary structure and other physicochemical properties
[19,20,36,37]. Therefore, abrin aggregation was carried out
at two di¡erent physiological temperatures, 25 and 37‡C, in
the presence of KA or KB-crystallin or HSP26. The relative
protection by KA-, KB-crystallin and HSP26 as a function of
temperature is shown in Fig. 6. Though KB-crystallin is more
e¡ective than KA in suppressing the aggregation of abrin at
25‡C, the di¡erence is only marginal. Unlike with insulin [19],
this di¡erence between KA- and KB-crystallins in suppressing
abrin aggregation is maintained at 37‡C also. With insulin it
was observed that KB-crystallin shows about three times more
chaperone activity than KA-crystallin at and around 25‡C
(Fig. 1) [19], but as the temperature is increased the di¡erence
between the chaperone potential of KA and KB-crystallins
decreases [19].
The mode of interaction of unfolded proteins or the so-
called non-native proteins with K-crystallin is of considerable
interest in understanding its chaperone activity. It is believed
that binding of non-native proteins to K-crystallin is driven by
hydrophobic interactions [12^16]. In addition, studies have
clearly shown that K-crystallin undergoes some structural/con-
formational changes under thermal and other conditions
[14,15,19,20,25,26]. Furthermore, in glycation and steroid-in-
duced enzyme inactivation studies, K-crystallins may also
undergo modi¢cations [30]. Therefore, it is important to
choose the conditions, which do not a¡ect K-crystallin struc-
ture and function. Insulin which can be unfolded by reduction
with DTT seems to be suitable, since K-crystallin has no di-
sul¢de bonds and therefore is una¡ected by the reduction.
Even under physiologically relevant temperatures (37^40‡C)
KB is more potent as a chaperone with respect to di¡erent
substrates tested including insulin [19]. The relative chaperone
activity of KA and KB varies with di¡erent substrates and at
di¡erent temperatures [19,20,37]. In general, the greater chap-
erone activity of KB (compared to KA) has been attributed to
its higher surface hydrophobicity.
In addition, recently we found no substantial di¡erence
between KA and KB in protecting the glucose-6-phosphate
dehydrogenase from in vitro UVB-induced inactivation [28].
Furthermore, irrespective of the similarity between abrin and
insulin with respect to aggregation upon disul¢de reduction,
unlike with insulin, KA and KB are invariably e¡ective in
suppressing the aggregation of abrin B-chain at both the tem-
peratures tested (Fig. 6). The assessment of ‘intrinsic’ chaper-
one activity of K-crystallin is therefore complicated by the
nature of substrate proteins, e¡ect of temperature and hydro-
phobicity. The present data thus provide a compelling evi-
dence that in addition to hydrophobicity the nature of the
substrate (i.e. length and topology?) may equally in£uence
the chaperone function of K-crystallin.
Fig. 6. The relative chaperone activity of KA-, KB-crystallin and
HSP26 against the aggregation of abrin B-chain at 25 and 37‡C.
Abrin (0.675 mg/ml in 50 mM phosphate bu¡er, pH 7.4, containing
100 mM NaCl) was reduced with 30 mM DTT in a ¢nal volume of
1 ml in the presence of 0.50 mg/ml of KA-, KB-crystallin or HSP26
and the aggregation was monitored by measuring the apparent ab-
sorption at 400 nm. The relative protection was calculated as de-
scribed in Section 2. Data represents meanTS.D. of three indepen-
dent experiments.
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The results of the present study thus reveal that due to its
relatively larger size, abrin may serve as a better substrate
for characterizing the mechanism of chaperone function of
K-crystallin and other sHSPs in vitro. Studies are underway
to investigate the structural elements of K-crystallin that are
involved in chaperoning abrin B-chain using synthetic pep-
tides that correspond to di¡erent regions of KA- or KB-crys-
tallins and site-directed mutagenesis approach.
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